| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Mai―20 |
Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study |
Paolo Zaurito, Hans Garmo, Rolf Gedeborg, Mats Ahlberg, Andri Wilberg Orrason, Johan Styrke, et al. (+3) David Robinson, Pär Stattin, Marcus Westerberg |
| 2 |
[GO] |
2022―Feb―09 |
Little support for a protective effect of ADT against COVID-19 |
Andreas Josefsson |
| 3 |
[GO] |
2021―Dez―23 |
Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer |
Rolf Gedeborg, Lars Lindhagen, Stacy Loeb, Johan Styrke, Hans Garmo, Pär Stattin |
| 4 |
[GO] |
2021―Mai―11 |
Patient perspective on telemedicine replacing physical consultations in urology during the COVID-19 lockdown in Denmark |
Emma Heeno, Irmelin Biesenbach, Charlotte Englund, Martin Lund, Anja Toft, Lars Lund |
| 5 |
[GO] |
2021―Apr―29 |
Prostate cancer diagnosis, staging, and treatment in Sweden during the first phase of the COVID-19 pandemic |
Giuseppe Fallara, Fredrik Sandin, Johan Styrke, Stefan Carlsson, Ingela Franck Lissbrant, Johan Ahlgren, et al. (+3) Ola Bratt, Mats Lambe, Pär Stattin |
| 6 |
[GO] |
2020―Jul―21 |
Cystoscopic surveillance for bladder cancer: Learning the lessons forced upon us by the Covid-19 pandemic* |
Hugh Mostafid |
|
